New data reinforce efficacy of Tecfidera®

[MSUK]

New data reinforce efficacy of Tecfidera® in MS patients with high disease activity

New data reinforce the efficacy of Tecfidera in a wide range of patients with relapsing-remitting multiple sclerosis (RRMS), as well as support its favorable safety and tolerability profile in the real-world setting. These data were presented by Biogen Idec at the 66th American Academy of Neurology (AAN) annual meeting in Philadelphia...... Read More - http://www.ms-uk.org/BG12